Jun 29, 2023 | Laboratory UTCBS, Research
Start-up Imisca and Erganeo have signed an exclusive license for a new gel-forming solution to reduce recurrence rates after local treatment of colorectal cancer, improve patient survival and optimize treatment. Colorectal cancer is one of the most common cancers,...
May 24, 2023 | Laboratory UTCBS, Research
Formulations based on phase transition polymers or “Sol-Gel” are an important part of our research. These formulations have the particularity to be totally liquid during manufacturing and to gel during their application, thus conferring multiple...
May 16, 2023 | Laboratory UTCBS, Research
Témoignages émouvants des premiers patients traités. Les mini-plasmides pFAR (Free of Antibiotic Resistance marker), développés pour des approches de Thérapie Génique au sein de l’UTCBS par Corinne Marie (ChimieParistech, PSL) et Daniel Scherman (CNRS), sont entrés...